Chiron Real Estate Inc. (XRN) Stock Price & Analysis

Chiron Real Estate Inc. (XRN) closed at USD 30.16 on Thursday, October 22, 2026, up 4.61% on the day. The US market is currently closed (pre-market); this is not a live price.

The prior close was USD 28.83; the Oct 22, 2026 session ranged USD 28.89–30.2 on volume of 363,193 shares. Market capitalization is $436.72M, with a 52-week range of USD 28.63–38.65 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 11:44 UTC.

Also available as compact Markdown for AI agents: nexqual.com/XRN.md

Key facts (XRN)

• Last four reported quarters (through Jun 30, 2026): revenue $153M, net income $62.7M (40.9% margin) (SEC filings).
• Valuation: P/E 7.0x (avg 54.8x at the last 2 fiscal year-ends).
• Insider open-market purchases, last ~7 months: 16 Form 4 filings, $3.2M; 0 by opportunistic insiders, 0 by routine insiders.
• Total return with dividends: 1Y +0.7% vs S&P 500 +14.9%; 5Y -43.5% vs S&P 500 +80.3%.
• Next earnings: 2026-11-04, EPS estimate USD -0.7, revenue estimate $38.3M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (XRN)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (XRN)

P/E 7.0x · P/S 2.9x · P/B 0.7x · Earnings yield 14.36% · Dividend yield (paid, TTM) 5.66%

P/E at fiscal year-ends: Dec 2024 76.1x, Dec 2023 33.5x.

Insider purchases (SEC Form 4, open-market, last ~7 months) (XRN)

16 purchases, $3.2M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Analysts (XRN)

Rating changes, last 120 days:

Total return (dividends reinvested) (XRN)

XRN revenue by business segment (quarter ended Jun 30, 2026)

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

XRN suppliers, customers and competitors (named in its 10-K)

Quoted from the company's 10-K filed Mar 2, 2026.

XRN company outlook (results filed Aug 5, 2026)

• “It is expected that The Landing and Riviera will deliver a yield on cost of greater than 7% upon stabilization in the second half of 2028.”
• “Hudson Active Adult Joint Venture: In May 2026, the Company paid $6.7 million to acquire a 49% equity interest in a 128-home Active Adult development in Hudson, Wisconsin (a suburb of Minneapolis, Minnesota), with completion expected in the fourth quarter of 2027.”
• “The Company expects to realize a high-teens levered IRR on its investment, inclusive of a $0.1 million acquisition fee paid to Chiron at closing.”
• “It is anticipated that this disposition will close in the fourth quarter. 3 Capital Markets During the quarter, the Company issued $100 million of its 6.00% Series C Convertible Perpetual Preferred stock (the “Series C Preferred Stock”) to an investor group led by Maewyn Capital Partners.”

Quoted word-for-word from the SEC 8-K results press release.

XRN analyst estimates and revisions

XRN options: expected move

Options price a move of about ±10.7% (±$3.23) by Nov 20, 2026, which includes earnings on Nov 4, 2026. Over the last 8 reports the stock moved ±4.3% on average.

30-day implied volatility 41.7% vs 28.5% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 23, 2026 at 11:44 UTC)

Technical Analysis (XRN)

Nexqual's technical model rates XRN "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 11:44 UTC.

Earnings (XRN)

Recent Earnings History

Source: Nexqual, October 23, 2026 at 11:44 UTC.

Financials & Fundamentals (XRN)

Source: Nexqual, October 23, 2026 at 11:44 UTC.

Ownership (XRN)

Source: Nexqual, October 23, 2026 at 11:44 UTC.

Leadership (XRN)

Chiron Real Estate Inc. is led by Mark O. Decker, President, CEO & Director, per Nexqual as of October 23, 2026 at 11:44 UTC.

Major Backers & Investors (XRN)

Notable institutional backers of Chiron Real Estate Inc. include Heartland Advisors Inc., HEARTLAND GROUP INC.-Heartland Value Fund, Alyeska Investment Group, L.p., according to Nexqual as of October 23, 2026 at 11:44 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, October 23, 2026 at 11:44 UTC.

From Chiron Real Estate Inc.'s Latest SEC 10-K Filing (filed 2026-03-02)

Key Strengths & Strategy (as disclosed to the SEC)

• Healthcare providers continue to face increased government pressure to control or reduce healthcare costs and ongoing adjustments to healthcare reimbursement, including payment rate changes and payment methodology reforms by the Centers for Medicare & Medicaid Services ("CMS"), as well as targeted efforts to strengthen program integrity and value-based care models.
• We believe this strategy allows us to attain our goals of providing stockholders with (i) attractive dividends and (ii) stock price appreciation.

Legal & Regulatory Risks (Item 1A, quoted)

• We are dependent on our tenants for our revenues. Our tenants face a wide range of business risks, including economic, competitive, government reimbursement and regulatory risks, any of which could cause our tenants to be unable to pay rent to us.
• We may incur environmental compliance costs and liabilities associated with owning, leasing, developing and operating our healthcare facilities.
• The healthcare industry is heavily regulated, and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of our tenants to make rent payments to us.
• Our tenants may be subject to significant legal actions that could subject them to increased operating costs and substantial uninsured liabilities, which may affect their ability to pay their rent payments to us, and we could also be subject to healthcare industry violations.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 11:44 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt